￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Safety and efficacy of nivolumab monotherapy in the treatment of advanced or metastatic squamous non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Effect data of nivolumab in treatment of previously treated advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Lung cancer immunotherapy welcomes new drug-nivolumab

2025-10-19 11:44:20

Check Details
Entrectinib brings new option for ROS1-positive lung cancer

2025-10-19 11:44:20

Check Details
Safety and effectiveness of ramucirumab combined with erlotinib in the treatment of EGFR mutated lung cancer

2025-10-19 11:44:20

Check Details
Will ramucirumab be included in the national medical insurance directory in 2021?

2025-10-19 11:44:20

Check Details
Data on the efficacy of entrectinib in the treatment of ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How much does a cycle of ramucirumab cost for lung cancer?

2025-10-19 11:44:20

Check Details
The difference between ramucirumab and bevacizumab_Canghule

2025-10-19 11:44:20

Check Details
Pictures and introduction of entrectinib targeted drug

2025-10-19 11:44:20

Check Details
Ramucirumab + docetaxel in the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Can ramucirumab be purchased in the country? How much does one cost?

2025-10-19 11:44:20

Check Details
Category
相关知识